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THE spread ofepithelial tumours to regional lymph nodes is regarded generally
as an earlier and more frequent event than blood borne metastasis, while sarcomas
are considered to metastasize by the blood stream rather than by lymphatics.
This impression is confirmed by published studies, although the evidence, as far
as we are aware, has never been well summarized. This difference in pattern of
spread is widely accepted and is mentioned in most pathology texts, as well as
in definitive works on the spread of tumours (e.g. WVillis, 1960; Cole, McDonald,
Roberts and Southwick, 1961). The differences between sarcomas and carcinomas
in this respect are far from absolute: many carcinomas apparently spread
exclusively by the blood stream, while lymph node metastases from sarcomas
are certainly not unknown. In any case, however, it is true that different indi-
vidual tumours differ in their pattern ofspread, some mainly involving lymphatics,
others spreading by the blood stream.
In the present study we considered mainly the problem of why some tumours
iinvolve lymph nodes earlier and more constantly than lung or liver. One explana-
tion might be the ease with which cells can enter lymphatics; the smaller channels
are visualized as an " open " system, into which cells and bacteria readily pass.
An alternative explanation is that, although both the venous and lymphatic
vessels may be readily invaded, the afferent lymph channels and subcapsular
sinuses oflymph nodes furnish a more suitable environment for successful transport
and growth of tumour cells; in comparison to rapid transit through veins, heart
and pulmonary vessels, with sudden impaction in pulmonary capillaries.
The present experiments therefore were designed to determine the incidence of
lymphatic and pulmonary tumours following the inoculation of a specified number
of tumour cells into lymphatic and venous channels. If the incidence were the
same in both groups, it would suggest that neither system represented a more
favourable " soil " for tumour growth and that preferential spread by tumours
to lymph nodes might be due rather to differences in permeability of blood vessels
and lymphatics.
Experimental studies on tumour spread in lymphatics have not been extensive.
Zeidman and Buss (1954) employed direct injection oftumour cells into lymphatic
channels using rabbits. Difficulties arise here in studying a variety of tumours
and using a large number of animals. Similar techniques applied to mice are
very difficult because of the size of the vessels. The rat, however, was shown by
Engeset (1959a and b) to be well suited to studies of this type. This worker
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devised techniques for inoculation oflymphatics both in the foot and the testicle.
The studies to be described utilized his method for injecting testicular lymphatics,
with parallel studies using testicular veins.
MATERIALS AND METHODS
Four tumours were studied as follows:
1. The Walker 256 carcinoma. This anaplastic tumour is probably of mam-
mary origin (Dunham and Stewart, 1953). It was studied in Sprague-Dawley
rats, which are not inbred, and the system is not anisologous one, although regres-
sion of tumours is uncommon.
2. The ML1 fibrosarcoma. This tumour was induced by subcutaneous injec-
tion of methylcholanthrene in Lewis rats. These rats are inbred (37 generations
at the time of study) and the tumour was in its third transplant generation.
The system was thus isologous in the usual sense, although the recent studies on
this type of tumour (Prehn, 1963) show that they may be weakly antigenic even
in an isologous system.
3. The IRC741 monocytic leukaemia. This tumour, which arose spon-
taneously in an inbred rat of the Fischer strain (Dunning and Curtis, 1957) was
maintained in descendants of the same strain purchased from the Charles River
Breeding Laboratories. Host and tumour were thus genetically similar but
probably not completely isologous.
4. The LL6 tumour. This is an anaplastic carcinoma, probably of mammary
origin, arising spontaneously in our inbred colony of Lewis rats. The tumour
was in its fifth transplant generation when used, and the system can be regarded
as isologous.
Pilot experiments were performed with each tumour to determine a range of
cell doses that would be likely to give a satisfactory comparison, since it was poss-
ible to find doses with each tumour that gave 100% or 0% of takes by either
route.
Tumour suspensions were preparedin each experimentbymincing solid tumour
to 1-2 mm. fragments with scalpels, and stirring the fragments in Earle's solution
containing 0 1% trypsin at 370 C. The supernatant containing single cells was
withdrawn and centrifuged at 700 r.p.m. for 20 minutes. The cells were resus-
pended in Earle's solution in the case of the Walker 256 tumour and in tissue
culture maintenance medium in the case of the other three tumours. Tumour
cell counts were made in a haemacytometer, excluding cells that stained with
trypan blue. Suspensions were then diluted to the required concentration.
All injections ofcells were made into the right testicle, after exposing the organ
through the scrotal skin under ether anaesthesia. The inoculations were made
through a 32-gauge needle (specially made and supplied through the kindness of
Becton, Dickinson & Co. ofCanada, Ltd.), the hub having been removed, and the
shaft attached to a 12-inch length ofpolyethylene tubing, size PE10. The other
end of the tubing was connected by an adapter to a 0 5 ml. tuberculin syringe.
All inocula were given in 0-05 ml. of volume.
Intralymphatic injections were made by inserting the needle into a lymphatic
channel on the surface of the testicle after injecting 0 5 ml. of saline into the
organ to dilate the lymphatics. These vessels have been described in some detail
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by Engeset (1959), but in our experience they vary with different strains of rats.
The Sprague-Dawley rat nearly always displays a straight and well-anchored
channel on the dorso-medial surface that is easily entered (Fig, 1). The Lewis and
Fischer strains show more variation, and recourse is often necessary to a more
moveable channel on the proximal pole. A small amount of trypan blue was
inoculated ahead of the tumour suspension, which was injected only when the fluid
was seen to enter the lymphatic. Injection required 45 to 60 seconds, otherwise
the fragile vessels tended to burst.
Intravenous injections were made easily into one of the flat venous tributaries
on the testicular surface. Following injections by either route, the spermatic
cord and vessels were ligated as high as possible and the testis removed. The
wound was closed with skin clips.
All animals were kept under observation until either dead or moribund, or for
a period of time beyond which tumours did not usually arise. Thus time varied
from 4 weeks in the case of the Walker 256 tumour to 6 months in the case ofthe
LL6 tumour. These periods of time are arbitrary; the essential point is that
both venous and lymphatic groups were always terminated at the same time.
All animals were autopsied and gross tumour in renal and lumbar nodes and in
lungs was recorded. Lymph nodes and one section of each lobe of the lungs were
examined microscopically.
RESULTS
The results are summarized in Tables I to IV. Although more detailed analysis
was made of the extent of lymph node involvement, number of nodes involved,
number of pulmonary tumours, the results are scored in the tables simply as
number of animals with tumours. It can be seen that, at high cell doses, none
of the tumours showed preferential growth in lymph nodes or lungs. However,
at low doses, the two carcinomas produced more tumours in lymph nodes when
administered by lymphatic channels, than pulmonary tumours by intravenous
inoculation. These differences are highly significant. The MLI sarcoma and the
IRC741 leukaemia failed to show any significant difference in the incidence of
tumours by lymphatic and venous routes, regardless ofthe number ofcells injected.
The tumours produced by intravenous inoculation were confined to the lung
in the case of the Walker 256, ML1 and LL6 tumours. Lymphatic injection of
these three tumours produced secondaries in lumbar and renal nodes. In most
cases both nodes were involved, but in a few animals only the lumbar node con-
tained tumour. The predominant involvement was always on the same side as
the injection, but the contralateral nodes occasionally contained tumour as well.
Pulmonary tumours were found in a few animals given lymphatic injections;
these were found only when lymph nodes were also involved as well. These
pulmonary tumours may represent metastases from the lymph nodes; they
may also be examples of direct passage from lymphatics to lung via the thoracic
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FiG. 1. Testicle of Sprague-Dawley rat with needle in a lymphatic. The needle is slightly
kinked in the vessel because of lack of support. The needle and tubing contain a solution
of trypan blue, which is darkening the proximal segment of the lymphatic. A network of
veins is also seen; intravenous injections were made into these in other animals.
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TABLE I.-Transplantation of Walker 256 Tumrnour by Intravenous
and Intralymphatic Routes
Number of animals with tumours
Number of cells
inoculated
1,000
10,000
100,000
Intravenous
route
0/8
3/8
9/10
Intralymphatic
route
7/8
9/10
8/9
TABLE II.-Transplantation of ML1 Sarcoma by Intravenous and
Intralymphatic Routes
Number of cells
inoculated
100
1,000
10,000
100,000
Number of animals with tumours
Intravenous Intralymphatic
route route
0/15 1/12
2/15 3/14 P= >005
4/14 4/15
7/17 12/17 J
TABLE III.-Transplantation ofIRC741 Leukaemia by Intravenous
and Intralymphatic Routes
Number of cells
inoculated
100
1,000
Number of animals with leukaemia
t - -.A
Intravenous Intralymphatic
route route
3/11 6/11 P = >0.05
8/10 10/10 P = >0.05
TABLE IV.-Transplantation ofLL6 Tumrnour by Intravenous and
Intralymphatic Routes
Number of cells .
inoculated
1,000
10,000
Number of animals with tumours
r~~~ ~~-- --A- -~
Intravenous Intralymphatic
route route
0/10
5/10
10/10
11/12
duct, as demonstrated by Engeset (1959a) and our own previous studies (Hollen-
berg, 1959).
The IRC741 leukaemia presented an entirely different picture when takes
occurred, and the picture was the same with lymphatic and venous inoculation.
It consisted of widespread involvement of lungs, liver, spleen, bone marrow and
lymph nodes, with terminal appearance of leukaemic cells in the blood. Neither
the extent of the leukaemia nor the survival times differed in the two groups.
DISCUSSION
The foregoing studies indicate that some tumours can be established from a
lower inoculum by lymphatic routes than by venous channels. Several factors
could explain this. It is possible but unlikely that immunological influences
P= <0.001
P = >0.05
P = >0005
P = <0.001
P = >0.05
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might operate less effectively on a tumour in a lymph node. The degree of
histocompatibility in the present systems used does not suggest this, since the
Walker 256 tumour was non-isologous with its host, while the LL6tumourwas
isologous. Simple dilution of the inoculum may be of importance in the effect.
A concentration, for example, of 1000 cells in 0 05 ml., will probably be diluted
much more by the time the cells have passed through the right heart and reached
the pulmonary bed than would a similar inoculum injected into a lymphatic
channel, all or most of the contents ofwhich would pass to a single small lymph
node. A simple " dilution " explanation for the results does not lessen their
significance, since the same difference in dilution may influence the fate ofhuman
tumour cells entering lymphatics or veins. The concentration of tumour cells in
pulmonary capillaries might be further reduced by passage of cells through the
capillary bed. Zeidman and Buss (1952) have shown that transpulnonary
passage of some tumours occurs commonly, while the same workers (1954) have
claimed that lymph nodes initially act as a complete barrier. A further factor
might be the nature of lymphatic channels and sinuses. Particularly, the latter
may furnish a sheltered nidus for proliferation of small numbers of cells.
While these studies suggest that lymphatic routes may permit metastatic
growth of smaller numbers of cells than venous routes, they do not exclude the
possibility that lymphatics are more easily entered by tumour cells. Nor do they
explain the fact that some tumours, notably sarcomas, appear to spread predomi-
nantly by the blood stream rather than by lymphatics.
SUMMARY
Fourtumours, including two carcinomas, a sarcomaand amonocyticleukaemia,
were inoculated into testicular veins and lymphatics, using counted numbers of
cells in suspension. It was found that the two carcinomas produced tumours
more readily in lymph nodes by lymphatic routes than pulmonary tumours by
venous routes. This difference was apparent only when low doses of oells were
used. The sarcoma and the leukaemia failed to show such differences at any dose
of cells. These results may furnish a partial explanation for the earlier and more
frequent metastases of carcinomas to lymph nodes as compared to lungs.
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